Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria | PLOS ONE
DOAC -Approved Indications and Dosing | Download Table
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Table 1 from Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical
Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation - ScienceDirect
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect
Frontiers | Efficacy and Safety of Non-recommended Dose of New Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
ELIQUIS® (apixaban) dosing for NVAF patients | ELIQUIS UK
DVT Prophylaxis After Hip/Knee Surgery|ELIQUIS® (apixaban) Safety Info
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS IRELAND
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS IRELAND
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS UK
Cureus | Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis | Article
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar
Eliquis Full Prescribing Information, Dosage & Side Effects | MIMS Malaysia
Anticoagulation therapy in Atrial Fibrillation patients at high bleeding risk - It's Over 9000!